HIT Consultant September 18, 2024
What You Should Know:
– A research study by CCS, a leading chronic care management company, reveals that patients receiving continuous glucose monitoring (CGM) devices through medical benefits experience superior adherence and lower costs compared to those accessing them through pharmacy benefits.
– The JMIR Diabetes research — Exploring Real-World Adherence and Cost Implications of Continuous Glucose Monitoring in Patients with Diabetes: Impact of Device Sourcing, highlights the critical role of benefit channel selection in optimizing diabetes management.
Key Findings
- Improved Adherence: Patients obtaining CGMs through the medical benefit demonstrated a 23% higher adherence rate.
- Increased Therapy Reinitiation: Non-adherent patients receiving CGMs through the medical benefit were 22% more likely to resume therapy, compared to only 10%...
Today's Sponsors
Today's Sponsor